Optimal diuretic strategies in heart failure

被引:8
|
作者
Suri, Sarabjeet S. [1 ]
Pamboukian, Salpy V. [1 ]
机构
[1] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA
关键词
Heart failure (HF); diuresis; diuretic resistance; FUROSEMIDE; TOLVAPTAN;
D O I
10.21037/atm-20-4600
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heart failure (HF) is one of the major causes of morbidity and mortality in the world. According to a 2019 American Heart Association report, about 6.2 million American adults had HF between 2013 and 2016, being responsible for almost 1 million admissions. As the population ages, the prevalence of HF is anticipated to increase, with 8 million Americans projected to have HF by 2030, posing a significant public health and financial burden. Acute decompensated HF (ADHF) is a syndrome characterized by volume overload and inadequate cardiac output associated with symptoms including some combination of exertional shortness of breath, orthopnea, paroxysmal nocturnal dyspnea (PND), fatigue, tissue congestion (e.g., peripheral edema) and decreased mentation. The pathology is characterized by hemodynamic abnormalities that result in autonomic imbalance with an increase in sympathetic activity, withdrawal of vagal activity and neurohormonal activation (NA) resulting in increased plasma volume in the setting of decreased sodium excretion, increased water retention and in turn an elevation of filling pressures. These neurohormonal changes are adaptive mechanisms which in the short term are associated with increased contractility of the left ventricular (LV) and improvement in cardiac output. But chronically, the failing heart is unable to overcome the excessive pressure and volume leading to worsening HF. The primary symptomatic management of ADHF includes intravenous (IV) diuresis to help with decongestion and return to euvolemic status. Even though diuretics have not been shown to provide any mortality benefit, they have been clinically proven to be of significant benefit in the acute decompensated phase, as well as in chronic management of HF. Loop diuretics remain the mainstay of therapy for symptomatic management of HF with use of thiazide diuretics for synergistic effect in the setting of diuretic resistance. Poor diuretic efficacy has been linked with higher mortality and increased rehospitalizations.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Heart transplantation in patients with diuretic resistant heart failure
    De Vivo, F
    De Santo, LS
    Maiello, C
    Marra, C
    Marmo, J
    Cotrufo, M
    MINERAL AND ELECTROLYTE METABOLISM, 1999, 25 (1-2) : 47 - 50
  • [42] DIURETIC STRATEGIES IN PATIENTS WITH RENAL-FAILURE
    SWAN, SK
    DRUGS, 1994, 48 (03) : 380 - 385
  • [43] Plasma Renin Activity (PRA) Predicts Diuretic Resistance in Acute Heart Failure Patients: An Ancillary Study of the Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE-AHF)
    Ohtani, Tomohito
    Felker, G. Michael
    McNulty, Steven E.
    LeWinter, Martin M.
    Braunwald, Eugene
    Redfield, Margaret M.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S25 - S26
  • [44] OPTIMAL INITIAL DIURETIC DOSE IN ACUTE DECOMPENSATED HEART FAILURE USING A HOME DOSE MULTIPLIER
    Mumtaz, Salmaan
    Rundhawa, Gohar
    Rehman, Aisha
    Patel, Dhruvil
    Patel, Krina
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 380 - 380
  • [45] Diuretic strategies in patients with acute decompensated heart failure and preserved left ventricular ejection fraction
    Ho, C. W.
    Ho, M. H.
    Cheung, H. L.
    Chan, T. M.
    Tse, H. F.
    Siu, C. W.
    EUROPEAN HEART JOURNAL, 2014, 35 : 159 - 160
  • [46] Merbaphen (novasurol) as a diuretic in congestive heart failure
    Marvin, HM
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1926, 87 : 1016 - 1020
  • [47] REPLY: Time to Diuretic in Acute Heart Failure
    Park, Jin Joo
    Choi, Dong-Ju
    JACC-HEART FAILURE, 2018, 6 (08) : 723 - 723
  • [48] HYDROCHLOROTHIAZIDE - A NEW DIURETIC FOR THE TREATMENT OF HEART FAILURE
    BARRE, E
    DANRIGAL, A
    RICHIER, JL
    LEBRANCHU, F
    PRESSE MEDICALE, 1960, 68 (02): : 29 - 31
  • [49] Diuretic therapy and resistance in congestive heart failure
    Ellison, DH
    CARDIOLOGY, 2001, 96 (3-4) : 132 - 143
  • [50] Decompensated heart failure and diuretic resistance - Reply
    Costanzo, Maria Rosa
    Sobotka, Paul A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (05) : 1060 - 1060